Ispire Q1 revenue falls 9.3% to $27.5m as European vape restrictions cut orders

Ispire Technology posted fiscal first-quarter revenue of $27.5 million, 9.3% below a year earlier, and a net loss of $6.4 million for the quarter ended 30 September 2026, the company said on its earnings call.

The loss equals $0.11 per share, against $0.06 a year earlier and $13.8 million in the preceding quarter. Adjusted EBITDA was positive at $136,000, down from $0.6 million a year earlier but up from a $2.3 million loss in the prior quarter.

European disposable bans and excise changes delayed distributor orders

CFO Jay Yu attributed the year-over-year decline mainly to weaker European sales. He said restrictions on vaping products, including disposable-product bans and changes in excise taxation, led distributors to hold back inventory and postpone purchases.

Gross profit fell to $4.5 million from $5.1 million, and gross margin slipped to 16.2% from 17%. Yu said competitive pricing pressure pulled down selling prices on some products; President Steven Przybyla said margin had returned to historical levels after prior-quarter inventory impairments and return charges.

Credit loss expense of $4.8 million drove operating costs up

Total operating expenses rose to $10.6 million from $7.8 million a year earlier, with $4.8 million of that from credit loss expense, against $1.8 million a year earlier and $9.2 million in the preceding quarter.

Stripping out credit losses, operating expenses were $5.9 million, down 3.7% year over year, Yu said. Net accounts receivable stood at $13.5 million, down 80% from their peak in the second quarter of fiscal 2025, according to Przybyla.

Przybyla said Ispire aims to complete the receivables cleanup in fiscal 2027 and expects no further major write-downs afterward. The company also won a $3.4 million judgment against a former customer in mid-October and has started enforcement; Przybyla said management believes it is fully collectible.

Malaysian production carries a claimed 25% tariff advantage for US exports

Przybyla described fiscal 2027 as the first full year of vapor and nicotine pouch output at Ispire’s company-owned Malaysian factories. He said Malaysian production holds roughly a 25% tariff advantage over Chinese production for shipments to the United States.

He also pointed to the planned end of China’s 13% export VAT rebate for e-cigarettes in April 2027 as a further tailwind for Malaysian output. Asked about pricing, Przybyla said quotes for large Malaysian orders are currently slightly above Chinese pricing, but he expects costs to be at least comparable as volumes scale and supply chains mature.

Cash and equivalents ended the quarter at $15.6 million, down from $19.3 million at 30 June, with total debt of $0.5 million. Operating activities used $1.6 million, a figure that includes a $3 million payment toward aged payables owed to a related-party manufacturer; excluding that payment, operations would have generated about $1.4 million, Przybyla said. Investing activities used $1.8 million, mostly a $1.6 million payment tied to the IKE joint venture.

Regional brand deal and IKE age-gating pilot are the near-term catalysts

Ispire is in the closing stages of a manufacturing and product-development deal with a regional Southeast Asian e-cigarette brand, Przybyla said. He hopes to announce the relationship in January 2027 and start production shortly after, and the company plans to enter nicotine pouches through its Jincheng Pharma joint venture and its Malaysian production licence.

Ispire holds 40% of IKE Tech, whose component premarket tobacco product application remains under FDA review. IKE released version 2.0 of its platform in September and will test it on certain Charlie’s Holdings PACHA disposable products, with an initial pilot expected through Smoker Friendly before the end of 2026; the companies expect the results to support updates to several of Charlie’s pending applications.

What the numbers change for suppliers and brand owners

Ispire’s results show how European disposable bans and excise changes move through the supply chain: distributors cut orders before rules bite, and manufacturers absorb the shortfall in revenue and receivables. VapeBrief’s analysis: brands sourcing from Chinese factories should expect pricing conversations to factor in tariff differentials and the scheduled April 2027 end of the 13% export VAT rebate, and should plan order timing around that date.

The receivables cleanup and the $4.8 million credit loss figure also signal that some customers did not pay, which raises the bar for credit terms on new accounts in regulated markets. Malaysian capacity is being positioned as an alternative for US-bound shipments, though the company concedes current quotes there are slightly higher than Chinese pricing.

Next dates

Ispire expects pilot results from the IKE 2.0 deployment through Smoker Friendly before the end of 2026, and aims to announce the Southeast Asian brand partnership in January 2027 with output following shortly afterward.

Questions readers ask

Why did Ispire's revenue fall in fiscal Q1?

CFO Jay Yu attributed the 9.3% year-over-year decline mainly to reduced European sales, after disposable-product bans and excise tax changes led distributors to hold back inventory and delay purchases.

What tariff advantage does Ispire claim for Malaysian production?

President Steven Przybyla said Malaysian production carries an approximately 25% tariff advantage over Chinese production for exports to the United States. He also cited the planned April 2027 end of China's 13% export VAT rebate for e-cigarettes as a further factor.